biotech news today obesity drugs glp-1 ADA '26: Lilly's dominance, Pfizer's 'foundational' drug and Roche's 'me-too' option GLP-1 Market Trends and Global

Sermorelin is a short-chain peptide fragment of GHRH that acts as a GH secretagogue, meaning it prompts the pituitary gland to produce more growth hormone

Doses Per Vial Vial duration varies by dose escalation phase: 3mg vial: At 0.25mg/week = 12 weeks At 0.5mg/week = 6 weeks At 1mg/week = 3 weeks At 2.4mg/week = 1.25 weeks 5mg vial: At 0.25mg/week = 20 weeks At 0.5mg/week = 10 weeks At 1mg/week = 5 weeks At 1.7mg/week = ~3 weeks At 2.4mg/week = ~2 weeks A 5mg vial can cover the entire first 4 months of a slow escalation protocol starting at 0.25mg

Here we explain what scientists know so far about oxytocins connection to autism

While GLP-1 will be released from intestinal cells upon consumption of food, the amount of insulin release that is triggered by GLP-1 varies due to the time of day.[ref] Diet changes rhythm: A Western Diet, high in fat and sugar, is used in research studies to induce obesity in animal models

Effects of repeated oral intake of a quercetin-containing supplement on allergic reaction: A randomized, placebo-controlled, double-blind parallel-group study